PD-1 Produits
(Programmed Cell Death 1 (PDCD1))
Catégories
This gene encodes a cell surface membrane protein of the immunoglobulin superfamily. This protein is expressed in pro-B-cells and is thought to play a role in their differentiation. In mice, expression of this gene is induced in the thymus when anti-CD3 antibodies are injected and large numbers of thymocytes undergo apoptosis. Mice deficient for this gene bred on a BALB/c background developed dilated cardiomyopathy and died from congestive heart failure. These studies suggest that this gene product may also be important in T cell function and contribute to the prevention of autoimmune diseases. [provided by RefSeq, Jul 2008].
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories PD-1 en vedette
PD-1 Anticorps
High quality antibodies with extensive validation data.
PD-1 Kits ELISA
Reliable ELISA kits for a wide range of species.
PD-1 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
PD-1 recommandé Anticorps
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human, Mouse, Rat
Application
FACS, WB, ELISA, IHC (p), IHC (fro), IF (p), IF (cc)
Validations
- (2)
- (3)
- (1)
N° du produit
ABIN735608
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, ELISA, IHC (p), ICC, IHC (fro)
Validations
- (8)
N° du produit
ABIN7440431
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
FACS, WB, ELISA
Validations
- (5)
N° du produit
ABIN7193563
Quantité
100 μL
Fiche technique
Fiche technique
PD-1 recommandé Kits ELISA
Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
- (1)
N° du produit
ABIN6958801
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Various Species
Analytical Method
Quantitative Competition ELISA
Validations
- (1)
N° du produit
ABIN6971295
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN6969576
Quantité
96 tests
Fiche technique
Fiche technique
PD-1 recommandé Protéines
Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Source
HEK-293 Cells
Validations
- (6)
N° du produit
ABIN7275419
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
HEK-293 Cells
Validations
- (6)
N° du produit
ABIN7275418
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
HEK-293 Cells
Validations
- (5)
N° du produit
ABIN7275420
Quantité
100 μg
Fiche technique
Fiche technique
Dernières publications sur nos produits PD-1
: "Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 Agents. ..." dans: Cancer immunology research, Vol. 9, Issue 12, pp. 1451-1464, (2022) (PubMed).: "Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors." dans: JCI insight, Vol. 6, Issue 20, (2021) (PubMed).
: "Self-Assembled Multivalent Aptamer Nanoparticles with Potential CAR-like Characteristics Could Activate T Cells and Inhibit Melanoma Growth." dans: Molecular therapy oncolytics, Vol. 17, pp. 9-20, (2020) (PubMed).
: "An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses." dans: Nature communications, Vol. 11, Issue 1, pp. 1395, (2020) (PubMed).
: "Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors." dans: EMBO molecular medicine, Vol. 12, Issue 6, pp. e11571, (2020) (PubMed).
: "Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity." dans: Cancer immunology, immunotherapy : CII, (2020) (PubMed).
: "Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma." dans: PLoS ONE, Vol. 13, Issue 7, pp. e0201222, (2019) (PubMed).
: "Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer." dans: Journal of the National Cancer Institute, Vol. 110, Issue 3, pp. 316-320, (2019) (PubMed).
: "Low levels of SIV-specific CD8+ T cells in germinal centers characterizes acute SIV infection." dans: PLoS pathogens, Vol. 15, Issue 3, pp. e1007311, (2019) (PubMed).
: "Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion." dans: Oncogenesis, Vol. 8, Issue 3, pp. 17, (2019) (PubMed).
Synonymes et noms alternatifs relatifs à PD-1
programmed cell death 1 (PDCD1), programmed cell death 1 (Pdcd1), CD279, hPD-1, hPD-l, Ly101, PD-1, PD1, Pdc1, SLEB2Protein level used designations for PD-1
- programmed cell death protein 1
- protein PD-1
- programmed cell death 1
- programmed death 1
- mPD-1
Vous êtes ici:
